Experimental Animals
Online ISSN : 1881-7122
Print ISSN : 1341-1357
ISSN-L : 0007-5124
Post-injury fecal microbiota transplantation attenuates experimental acute lung injury in rats
Zhenqiang ZHANG, Weitong ZENG, Zongjin LI, Longxiong LIAO, Biying DONG, Dongwei ZHANG
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 26-0168

Details
Abstract

Acute lung injury (ALI) is characterized by inflammatory alveolar-capillary barrier disruption and pulmonary edema, and effective therapies that modify the post-injury course remain limited. We investigated whether fecal microbiota transplantation (FMT) initiated after injury attenuates lipopolysaccharide (LPS)-induced ALI in rats. Eighteen male Sprague-Dawley rats were randomly assigned to control, LPS, and FMT+LPS groups (n=6/group). Beginning 24 h after LPS exposure, FMT+LPS rats received fresh fecal suspension by oral gavage twice daily for 7 days. Compared with LPS alone, FMT was associated with a lower lung wet-to-dry ratio, lower blinded lung-injury scores, and less severe histopathological abnormalities. TUNEL positivity, PHLDA1, cleaved Caspase-3, and Bax were lower, whereas Bcl-2 was higher in lung tissue. The measured inflammatory mediators in bronchoalveolar lavage fluid and serum were also lower after FMT, accompanied by lower pulmonary NF-κB/STAT3-associated molecular markers. Terminal fecal 16S rRNA analysis showed no significant restoration of alpha diversity, but pairwise PERMANOVA supported a community-level difference between LPS and FMT+LPS groups without significant pairwise dispersion heterogeneity. No individual taxon remained significant after false-discovery-rate correction. These findings indicate that repeated post-injury FMT is associated with attenuation of pulmonary injury and inflammation, accompanied by apoptosis-related changes and a shift in terminal fecal microbial community structure.

Content from these authors
© 2026 Japanese Association for Laboratory Animal Science

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top